PubMed:19880293
Annnotations
LitCoin-sentences
{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":66},"obj":"Sentence"},{"id":"T2","span":{"begin":67,"end":78},"obj":"Sentence"},{"id":"T3","span":{"begin":79,"end":172},"obj":"Sentence"},{"id":"T4","span":{"begin":173,"end":298},"obj":"Sentence"},{"id":"T5","span":{"begin":299,"end":450},"obj":"Sentence"},{"id":"T6","span":{"begin":451,"end":590},"obj":"Sentence"},{"id":"T7","span":{"begin":591,"end":653},"obj":"Sentence"},{"id":"T8","span":{"begin":654,"end":664},"obj":"Sentence"},{"id":"T9","span":{"begin":665,"end":786},"obj":"Sentence"},{"id":"T10","span":{"begin":787,"end":795},"obj":"Sentence"},{"id":"T11","span":{"begin":796,"end":939},"obj":"Sentence"},{"id":"T12","span":{"begin":940,"end":1204},"obj":"Sentence"},{"id":"T13","span":{"begin":1205,"end":1362},"obj":"Sentence"},{"id":"T14","span":{"begin":1363,"end":1371},"obj":"Sentence"},{"id":"T15","span":{"begin":1372,"end":1609},"obj":"Sentence"},{"id":"T16","span":{"begin":1610,"end":1750},"obj":"Sentence"},{"id":"T17","span":{"begin":1751,"end":1890},"obj":"Sentence"},{"id":"T18","span":{"begin":1891,"end":2004},"obj":"Sentence"},{"id":"T19","span":{"begin":2005,"end":2225},"obj":"Sentence"},{"id":"T20","span":{"begin":2226,"end":2359},"obj":"Sentence"},{"id":"T21","span":{"begin":2360,"end":2467},"obj":"Sentence"},{"id":"T22","span":{"begin":2468,"end":2520},"obj":"Sentence"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-entities
{"project":"LitCoin-entities","denotations":[{"id":"6660","span":{"begin":21,"end":26},"obj":"GeneOrGeneProduct"},{"id":"6661","span":{"begin":47,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6662","span":{"begin":57,"end":65},"obj":"OrganismTaxon"},{"id":"6663","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6664","span":{"begin":101,"end":124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6665","span":{"begin":173,"end":176},"obj":"GeneOrGeneProduct"},{"id":"6666","span":{"begin":179,"end":183},"obj":"GeneOrGeneProduct"},{"id":"6667","span":{"begin":278,"end":297},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6668","span":{"begin":363,"end":368},"obj":"GeneOrGeneProduct"},{"id":"6669","span":{"begin":521,"end":526},"obj":"GeneOrGeneProduct"},{"id":"6670","span":{"begin":569,"end":589},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6671","span":{"begin":618,"end":623},"obj":"GeneOrGeneProduct"},{"id":"6672","span":{"begin":632,"end":641},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6673","span":{"begin":710,"end":715},"obj":"GeneOrGeneProduct"},{"id":"6674","span":{"begin":748,"end":757},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6675","span":{"begin":840,"end":848},"obj":"OrganismTaxon"},{"id":"6676","span":{"begin":854,"end":863},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6677","span":{"begin":872,"end":881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6678","span":{"begin":973,"end":978},"obj":"GeneOrGeneProduct"},{"id":"6679","span":{"begin":985,"end":1004},"obj":"SequenceVariant"},{"id":"6680","span":{"begin":1006,"end":1016},"obj":"SequenceVariant"},{"id":"6681","span":{"begin":1018,"end":1027},"obj":"SequenceVariant"},{"id":"6682","span":{"begin":1029,"end":1042},"obj":"SequenceVariant"},{"id":"6683","span":{"begin":1047,"end":1056},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6684","span":{"begin":1057,"end":1065},"obj":"OrganismTaxon"},{"id":"6685","span":{"begin":1115,"end":1124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6686","span":{"begin":1125,"end":1133},"obj":"OrganismTaxon"},{"id":"6687","span":{"begin":1404,"end":1413},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6688","span":{"begin":1438,"end":1443},"obj":"GeneOrGeneProduct"},{"id":"6689","span":{"begin":1444,"end":1452},"obj":"SequenceVariant"},{"id":"6690","span":{"begin":1591,"end":1599},"obj":"SequenceVariant"},{"id":"6691","span":{"begin":1650,"end":1659},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6692","span":{"begin":1684,"end":1689},"obj":"GeneOrGeneProduct"},{"id":"6693","span":{"begin":1690,"end":1701},"obj":"SequenceVariant"},{"id":"6694","span":{"begin":1869,"end":1880},"obj":"SequenceVariant"},{"id":"6695","span":{"begin":1954,"end":1959},"obj":"GeneOrGeneProduct"},{"id":"6696","span":{"begin":1959,"end":1977},"obj":"SequenceVariant"},{"id":"6697","span":{"begin":1981,"end":1986},"obj":"GeneOrGeneProduct"},{"id":"6698","span":{"begin":1986,"end":1994},"obj":"SequenceVariant"},{"id":"6699","span":{"begin":2040,"end":2045},"obj":"GeneOrGeneProduct"},{"id":"6700","span":{"begin":2045,"end":2056},"obj":"SequenceVariant"},{"id":"6701","span":{"begin":2153,"end":2162},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6702","span":{"begin":2163,"end":2171},"obj":"OrganismTaxon"},{"id":"6703","span":{"begin":2241,"end":2246},"obj":"GeneOrGeneProduct"},{"id":"6704","span":{"begin":2247,"end":2261},"obj":"SequenceVariant"},{"id":"6705","span":{"begin":2303,"end":2312},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6706","span":{"begin":2313,"end":2321},"obj":"OrganismTaxon"},{"id":"6707","span":{"begin":2373,"end":2378},"obj":"GeneOrGeneProduct"},{"id":"6708","span":{"begin":2429,"end":2438},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A27","pred":"db_id","subj":"6686","obj":"NCBITaxon:9606"},{"id":"A48","pred":"db_id","subj":"6707","obj":"NCBIGene:50943"},{"id":"A21","pred":"db_id","subj":"6680","obj":"c|SUB|A|-3279|C"},{"id":"A37","pred":"db_id","subj":"6696","obj":"c|DEL|-6054|ATT"},{"id":"A46","pred":"db_id","subj":"6705","obj":"MESH:D011565"},{"id":"A9","pred":"db_id","subj":"6668","obj":"NCBIGene:50943"},{"id":"A12","pred":"db_id","subj":"6671","obj":"NCBIGene:50943"},{"id":"A15","pred":"db_id","subj":"6674","obj":"MESH:D011565"},{"id":"A1","pred":"db_id","subj":"6660","obj":"NCBIGene:50943"},{"id":"A5","pred":"db_id","subj":"6664","obj":"MESH:D012871"},{"id":"A45","pred":"db_id","subj":"6704","obj":"c|Allele|GA|IVS9+459"},{"id":"A43","pred":"db_id","subj":"6702","obj":"NCBITaxon:9606"},{"id":"A24","pred":"db_id","subj":"6683","obj":"MESH:D011565"},{"id":"A30","pred":"db_id","subj":"6689","obj":"c|Allele|AC|-3297"},{"id":"A34","pred":"db_id","subj":"6693","obj":"c|Allele|GG|IVS9+459"},{"id":"A39","pred":"db_id","subj":"6698","obj":"c|SUB|A|-924|G"},{"id":"A16","pred":"db_id","subj":"6675","obj":"NCBITaxon:9606"},{"id":"A3","pred":"db_id","subj":"6662","obj":"NCBITaxon:9606"},{"id":"A25","pred":"db_id","subj":"6684","obj":"NCBITaxon:9606"},{"id":"A49","pred":"db_id","subj":"6708","obj":"MESH:D011565"},{"id":"A7","pred":"db_id","subj":"6666","obj":"NCBIGene:3559"},{"id":"A10","pred":"db_id","subj":"6669","obj":"NCBIGene:50943"},{"id":"A17","pred":"db_id","subj":"6676","obj":"MESH:D011565"},{"id":"A36","pred":"db_id","subj":"6695","obj":"NCBIGene:50943"},{"id":"A23","pred":"db_id","subj":"6682","obj":"c|SUB|A|IVS9+459|G"},{"id":"A38","pred":"db_id","subj":"6697","obj":"NCBIGene:50943"},{"id":"A42","pred":"db_id","subj":"6701","obj":"MESH:D011565"},{"id":"A44","pred":"db_id","subj":"6703","obj":"NCBIGene:50943"},{"id":"A14","pred":"db_id","subj":"6673","obj":"NCBIGene:50943"},{"id":"A19","pred":"db_id","subj":"6678","obj":"NCBIGene:50943"},{"id":"A32","pred":"db_id","subj":"6691","obj":"MESH:D011565"},{"id":"A26","pred":"db_id","subj":"6685","obj":"MESH:D011565"},{"id":"A28","pred":"db_id","subj":"6687","obj":"MESH:D011565"},{"id":"A20","pred":"db_id","subj":"6679","obj":"c|DEL|-6054|ATT"},{"id":"A41","pred":"db_id","subj":"6700","obj":"c|Allele|AC|-3279"},{"id":"A4","pred":"db_id","subj":"6663","obj":"MESH:D011565"},{"id":"A6","pred":"db_id","subj":"6665","obj":"NCBIGene:920"},{"id":"A8","pred":"db_id","subj":"6667","obj":"MESH:D001327"},{"id":"A29","pred":"db_id","subj":"6688","obj":"NCBIGene:50943"},{"id":"A13","pred":"db_id","subj":"6672","obj":"MESH:D011565"},{"id":"A35","pred":"db_id","subj":"6694","obj":"c|Allele|AA|IVS9+459"},{"id":"A11","pred":"db_id","subj":"6670","obj":"MESH:D001327"},{"id":"A22","pred":"db_id","subj":"6681","obj":"c|SUB|A|-924|G"},{"id":"A40","pred":"db_id","subj":"6699","obj":"NCBIGene:50943"},{"id":"A18","pred":"db_id","subj":"6677","obj":"MESH:D011565"},{"id":"A33","pred":"db_id","subj":"6692","obj":"NCBIGene:50943"},{"id":"A31","pred":"db_id","subj":"6690","obj":"c|Allele|CC|-3279"},{"id":"A47","pred":"db_id","subj":"6706","obj":"NCBITaxon:9606"},{"id":"A2","pred":"db_id","subj":"6661","obj":"MESH:D011565"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin_Mondo
{"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":47,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":278,"end":297},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":632,"end":641},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":748,"end":757},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T6","span":{"begin":854,"end":863},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T7","span":{"begin":872,"end":881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":1404,"end":1413},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":1650,"end":1659},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":2153,"end":2162},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":2303,"end":2312},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":2429,"end":2438},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"0005083"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0005083"},{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0005083"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"0005083"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"0005083"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"0005083"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"0005083"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0007179"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"0005083"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"0005083"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0005083"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0005083"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-GeneOrGeneProduct-v0
{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":21,"end":26},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":47,"end":56},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":79,"end":88},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":173,"end":176},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":179,"end":183},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":200,"end":205},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":207,"end":213},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":299,"end":305},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":318,"end":327},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":328,"end":361},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":363,"end":368},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":443,"end":449},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":521,"end":526},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":618,"end":623},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":632,"end":641},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":645,"end":652},"obj":"GeneOrGeneProduct"},{"id":"T17","span":{"begin":710,"end":715},"obj":"GeneOrGeneProduct"},{"id":"T18","span":{"begin":748,"end":757},"obj":"GeneOrGeneProduct"},{"id":"T19","span":{"begin":787,"end":794},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":810,"end":815},"obj":"GeneOrGeneProduct"},{"id":"T21","span":{"begin":816,"end":820},"obj":"GeneOrGeneProduct"},{"id":"T22","span":{"begin":854,"end":863},"obj":"GeneOrGeneProduct"},{"id":"T23","span":{"begin":872,"end":881},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":973,"end":978},"obj":"GeneOrGeneProduct"},{"id":"T25","span":{"begin":1100,"end":1111},"obj":"GeneOrGeneProduct"},{"id":"T26","span":{"begin":1152,"end":1157},"obj":"GeneOrGeneProduct"},{"id":"T27","span":{"begin":1197,"end":1202},"obj":"GeneOrGeneProduct"},{"id":"T28","span":{"begin":1347,"end":1351},"obj":"GeneOrGeneProduct"},{"id":"T29","span":{"begin":1404,"end":1413},"obj":"GeneOrGeneProduct"},{"id":"T30","span":{"begin":1438,"end":1443},"obj":"GeneOrGeneProduct"},{"id":"T31","span":{"begin":1518,"end":1523},"obj":"GeneOrGeneProduct"},{"id":"T32","span":{"begin":1650,"end":1659},"obj":"GeneOrGeneProduct"},{"id":"T33","span":{"begin":1684,"end":1689},"obj":"GeneOrGeneProduct"},{"id":"T34","span":{"begin":1954,"end":1959},"obj":"GeneOrGeneProduct"},{"id":"T35","span":{"begin":1981,"end":1986},"obj":"GeneOrGeneProduct"},{"id":"T36","span":{"begin":2040,"end":2045},"obj":"GeneOrGeneProduct"},{"id":"T37","span":{"begin":2051,"end":2056},"obj":"GeneOrGeneProduct"},{"id":"T38","span":{"begin":2099,"end":2104},"obj":"GeneOrGeneProduct"},{"id":"T39","span":{"begin":2153,"end":2162},"obj":"GeneOrGeneProduct"},{"id":"T40","span":{"begin":2173,"end":2177},"obj":"GeneOrGeneProduct"},{"id":"T41","span":{"begin":2241,"end":2246},"obj":"GeneOrGeneProduct"},{"id":"T42","span":{"begin":2303,"end":2312},"obj":"GeneOrGeneProduct"},{"id":"T43","span":{"begin":2373,"end":2378},"obj":"GeneOrGeneProduct"},{"id":"T44","span":{"begin":2429,"end":2438},"obj":"GeneOrGeneProduct"},{"id":"T45","span":{"begin":2511,"end":2519},"obj":"GeneOrGeneProduct"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-GeneOrGeneProduct-v2
{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":21,"end":26},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":47,"end":56},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":79,"end":88},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":179,"end":183},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":318,"end":327},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":328,"end":361},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":363,"end":368},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":521,"end":526},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":618,"end":623},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":632,"end":641},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":645,"end":652},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":710,"end":715},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":748,"end":757},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":854,"end":863},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":872,"end":881},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":973,"end":978},"obj":"GeneOrGeneProduct"},{"id":"T17","span":{"begin":1404,"end":1413},"obj":"GeneOrGeneProduct"},{"id":"T18","span":{"begin":1438,"end":1443},"obj":"GeneOrGeneProduct"},{"id":"T19","span":{"begin":1518,"end":1523},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":1650,"end":1659},"obj":"GeneOrGeneProduct"},{"id":"T21","span":{"begin":1684,"end":1689},"obj":"GeneOrGeneProduct"},{"id":"T22","span":{"begin":1954,"end":1959},"obj":"GeneOrGeneProduct"},{"id":"T23","span":{"begin":1981,"end":1986},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":2040,"end":2045},"obj":"GeneOrGeneProduct"},{"id":"T25","span":{"begin":2051,"end":2056},"obj":"GeneOrGeneProduct"},{"id":"T26","span":{"begin":2153,"end":2162},"obj":"GeneOrGeneProduct"},{"id":"T27","span":{"begin":2241,"end":2246},"obj":"GeneOrGeneProduct"},{"id":"T28","span":{"begin":2303,"end":2312},"obj":"GeneOrGeneProduct"},{"id":"T29","span":{"begin":2373,"end":2378},"obj":"GeneOrGeneProduct"},{"id":"T30","span":{"begin":2429,"end":2438},"obj":"GeneOrGeneProduct"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-Disease-MeSH
{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":47,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":278,"end":297},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":632,"end":641},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":748,"end":757},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T6","span":{"begin":854,"end":863},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T7","span":{"begin":872,"end":881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":1404,"end":1413},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":1650,"end":1659},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":2153,"end":2162},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":2303,"end":2312},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":2429,"end":2438},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A8","pred":"originalLabel","subj":"T8","obj":"D011565"},{"id":"A9","pred":"originalLabel","subj":"T9","obj":"D011565"},{"id":"A5","pred":"originalLabel","subj":"T5","obj":"D011565"},{"id":"A11","pred":"originalLabel","subj":"T11","obj":"D011565"},{"id":"A2","pred":"originalLabel","subj":"T2","obj":"D011565"},{"id":"A12","pred":"originalLabel","subj":"T12","obj":"D011565"},{"id":"A4","pred":"originalLabel","subj":"T4","obj":"D011565"},{"id":"A10","pred":"originalLabel","subj":"T10","obj":"D011565"},{"id":"A6","pred":"originalLabel","subj":"T6","obj":"D011565"},{"id":"A7","pred":"originalLabel","subj":"T7","obj":"D011565"},{"id":"A1","pred":"originalLabel","subj":"T1","obj":"D011565"},{"id":"A3","pred":"originalLabel","subj":"T3","obj":"D001327"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-GeneOrGeneProduct-v3
{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":21,"end":26},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":179,"end":183},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":318,"end":327},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":328,"end":361},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":363,"end":368},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":521,"end":526},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":618,"end":623},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":710,"end":715},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":973,"end":978},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":1438,"end":1443},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":1684,"end":1689},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":1954,"end":1959},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":1981,"end":1986},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":2040,"end":2045},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":2241,"end":2246},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":2373,"end":2378},"obj":"GeneOrGeneProduct"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin_Mondo_095
{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":47,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":278,"end":297},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":569,"end":589},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":632,"end":641},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T6","span":{"begin":748,"end":757},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T7","span":{"begin":854,"end":863},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":872,"end":881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":1404,"end":1413},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":1597,"end":1599},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":1650,"end":1659},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":2153,"end":2162},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T13","span":{"begin":2303,"end":2312},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14","span":{"begin":2429,"end":2438},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"0005083"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"0005083"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"0005083"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"0005083"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0005083"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0007179"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"0019087"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"0005083"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"0005083"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"0007179"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"0005083"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"0005083"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0005083"},{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0005083"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-MeSH-Disease-2
{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":47,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":101,"end":124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":278,"end":297},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":569,"end":589},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T6","span":{"begin":632,"end":641},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T7","span":{"begin":748,"end":757},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":854,"end":863},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":872,"end":881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":1047,"end":1056},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":1115,"end":1124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":1404,"end":1413},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T13","span":{"begin":1650,"end":1659},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14","span":{"begin":2153,"end":2162},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T15","span":{"begin":2303,"end":2312},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T16","span":{"begin":2429,"end":2438},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A15","pred":"ID:","subj":"T15","obj":"D011565"},{"id":"A12","pred":"ID:","subj":"T12","obj":"D011565"},{"id":"A8","pred":"ID:","subj":"T8","obj":"D011565"},{"id":"A7","pred":"ID:","subj":"T7","obj":"D011565"},{"id":"A13","pred":"ID:","subj":"T13","obj":"D011565"},{"id":"A5","pred":"ID:","subj":"T5","obj":"DISEASE"},{"id":"A4","pred":"ID:","subj":"T4","obj":"D001327"},{"id":"A14","pred":"ID:","subj":"T14","obj":"D011565"},{"id":"A6","pred":"ID:","subj":"T6","obj":"D011565"},{"id":"A11","pred":"ID:","subj":"T11","obj":"DISEASE"},{"id":"A16","pred":"ID:","subj":"T16","obj":"D011565"},{"id":"A1","pred":"ID:","subj":"T1","obj":"D011565"},{"id":"A3","pred":"ID:","subj":"T3","obj":"DISEASE"},{"id":"A9","pred":"ID:","subj":"T9","obj":"D011565"},{"id":"A10","pred":"ID:","subj":"T10","obj":"DISEASE"},{"id":"A2","pred":"ID:","subj":"T2","obj":"D011565"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-MONDO_bioort2019
{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":47,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":101,"end":124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":278,"end":297},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":569,"end":589},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T6","span":{"begin":632,"end":641},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T7","span":{"begin":748,"end":757},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":854,"end":863},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":872,"end":881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T10","span":{"begin":1047,"end":1056},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T11","span":{"begin":1115,"end":1124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12","span":{"begin":1404,"end":1413},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T13","span":{"begin":1650,"end":1659},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T14","span":{"begin":2153,"end":2162},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T15","span":{"begin":2303,"end":2312},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T16","span":{"begin":2429,"end":2438},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A15","pred":"#label","subj":"T15","obj":"D011565"},{"id":"A8","pred":"#label","subj":"T8","obj":"D011565"},{"id":"A7","pred":"#label","subj":"T7","obj":"D011565"},{"id":"A3","pred":"#label","subj":"T3","obj":"DISEASE"},{"id":"A5","pred":"#label","subj":"T5","obj":"DISEASE"},{"id":"A1","pred":"#label","subj":"T1","obj":"D011565"},{"id":"A4","pred":"#label","subj":"T4","obj":"D001327"},{"id":"A6","pred":"#label","subj":"T6","obj":"D011565"},{"id":"A11","pred":"#label","subj":"T11","obj":"DISEASE"},{"id":"A16","pred":"#label","subj":"T16","obj":"D011565"},{"id":"A2","pred":"#label","subj":"T2","obj":"D011565"},{"id":"A10","pred":"#label","subj":"T10","obj":"DISEASE"},{"id":"A9","pred":"#label","subj":"T9","obj":"D011565"},{"id":"A14","pred":"#label","subj":"T14","obj":"D011565"},{"id":"A12","pred":"#label","subj":"T12","obj":"D011565"},{"id":"A13","pred":"#label","subj":"T13","obj":"D011565"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-NCBITaxon-2
{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T1","span":{"begin":57,"end":65},"obj":"OrganismTaxon"},{"id":"T2","span":{"begin":840,"end":848},"obj":"OrganismTaxon"},{"id":"T3","span":{"begin":1057,"end":1065},"obj":"OrganismTaxon"},{"id":"T4","span":{"begin":1125,"end":1133},"obj":"OrganismTaxon"},{"id":"T5","span":{"begin":2163,"end":2171},"obj":"OrganismTaxon"},{"id":"T6","span":{"begin":2313,"end":2321},"obj":"OrganismTaxon"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
LitCoin-training-merged
{"project":"LitCoin-training-merged","denotations":[{"id":"T16","span":{"begin":2373,"end":2378},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":2241,"end":2246},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":2040,"end":2045},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":1981,"end":1986},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":1954,"end":1959},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":1684,"end":1689},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":1438,"end":1443},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":973,"end":978},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":710,"end":715},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":618,"end":623},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":521,"end":526},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":363,"end":368},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":328,"end":361},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":318,"end":327},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":179,"end":183},"obj":"GeneOrGeneProduct"},{"id":"T1","span":{"begin":21,"end":26},"obj":"GeneOrGeneProduct"},{"id":"T75109","span":{"begin":2429,"end":2438},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T48189","span":{"begin":2303,"end":2312},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T47728","span":{"begin":2153,"end":2162},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T66729","span":{"begin":1650,"end":1659},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T43987","span":{"begin":1404,"end":1413},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T75163","span":{"begin":1115,"end":1124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T77545","span":{"begin":1047,"end":1056},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T84232","span":{"begin":872,"end":881},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T12565","span":{"begin":854,"end":863},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T81312","span":{"begin":748,"end":757},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T67702","span":{"begin":632,"end":641},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T61818","span":{"begin":569,"end":589},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T82203","span":{"begin":278,"end":297},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T31508","span":{"begin":101,"end":124},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T46991","span":{"begin":79,"end":88},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T32280","span":{"begin":47,"end":56},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T61850","span":{"begin":2313,"end":2321},"obj":"OrganismTaxon"},{"id":"T94228","span":{"begin":2163,"end":2171},"obj":"OrganismTaxon"},{"id":"T91588","span":{"begin":1125,"end":1133},"obj":"OrganismTaxon"},{"id":"T32175","span":{"begin":1057,"end":1065},"obj":"OrganismTaxon"},{"id":"T56468","span":{"begin":840,"end":848},"obj":"OrganismTaxon"},{"id":"T91259","span":{"begin":57,"end":65},"obj":"OrganismTaxon"}],"attributes":[{"id":"A6","pred":"#label","subj":"T67702","obj":"D011565"},{"id":"A15","pred":"#label","subj":"T48189","obj":"D011565"},{"id":"A7","pred":"#label","subj":"T81312","obj":"D011565"},{"id":"A1","pred":"#label","subj":"T32280","obj":"D011565"},{"id":"A16","pred":"#label","subj":"T75109","obj":"D011565"},{"id":"A2","pred":"#label","subj":"T46991","obj":"D011565"},{"id":"A12","pred":"#label","subj":"T43987","obj":"D011565"},{"id":"A10","pred":"#label","subj":"T77545","obj":"DISEASE"},{"id":"A9","pred":"#label","subj":"T84232","obj":"D011565"},{"id":"A4","pred":"#label","subj":"T82203","obj":"D001327"},{"id":"A13","pred":"#label","subj":"T66729","obj":"D011565"},{"id":"A8","pred":"#label","subj":"T12565","obj":"D011565"},{"id":"A3","pred":"#label","subj":"T31508","obj":"DISEASE"},{"id":"A5","pred":"#label","subj":"T61818","obj":"DISEASE"},{"id":"A14","pred":"#label","subj":"T47728","obj":"D011565"},{"id":"A11","pred":"#label","subj":"T75163","obj":"DISEASE"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
DisGeNET
{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":1438,"end":1443},"obj":"gene:50943"},{"id":"T1","span":{"begin":1404,"end":1413},"obj":"disease:C0033860"},{"id":"T2","span":{"begin":1684,"end":1689},"obj":"gene:50943"},{"id":"T3","span":{"begin":1650,"end":1659},"obj":"disease:C0033860"},{"id":"T4","span":{"begin":2373,"end":2378},"obj":"gene:50943"},{"id":"T5","span":{"begin":2429,"end":2438},"obj":"disease:C0033860"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"},{"id":"R3","pred":"associated_with","subj":"T4","obj":"T5"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
Allie
{"project":"Allie","denotations":[{"id":"SS1_19880293_5_0","span":{"begin":475,"end":506},"obj":"expanded"},{"id":"SS2_19880293_5_0","span":{"begin":508,"end":512},"obj":"abbr"},{"id":"SS1_19880293_12_0","span":{"begin":1248,"end":1276},"obj":"expanded"},{"id":"SS2_19880293_12_0","span":{"begin":1278,"end":1285},"obj":"abbr"},{"id":"SS1_19880293_12_1","span":{"begin":1301,"end":1345},"obj":"expanded"},{"id":"SS2_19880293_12_1","span":{"begin":1347,"end":1351},"obj":"abbr"}],"relations":[{"id":"AE1_19880293_5_0","pred":"abbreviatedTo","subj":"SS1_19880293_5_0","obj":"SS2_19880293_5_0"},{"id":"AE1_19880293_12_0","pred":"abbreviatedTo","subj":"SS1_19880293_12_0","obj":"SS2_19880293_12_0"},{"id":"AE1_19880293_12_1","pred":"abbreviatedTo","subj":"SS1_19880293_12_1","obj":"SS2_19880293_12_1"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
DisGeNET5_gene_disease
{"project":"DisGeNET5_gene_disease","denotations":[{"id":"19880293-16#0#5#gene50943","span":{"begin":2373,"end":2378},"obj":"gene50943"},{"id":"19880293-16#56#65#diseaseC0033860","span":{"begin":2429,"end":2438},"obj":"diseaseC0033860"},{"id":"19880293-2#6#10#gene3559","span":{"begin":179,"end":183},"obj":"gene3559"},{"id":"19880293-2#6#10#gene3669","span":{"begin":179,"end":183},"obj":"gene3669"},{"id":"19880293-2#105#124#diseaseC0004364","span":{"begin":278,"end":297},"obj":"diseaseC0004364"},{"id":"19880293-4#70#75#gene50943","span":{"begin":521,"end":526},"obj":"gene50943"},{"id":"19880293-4#118#138#diseaseC0004364","span":{"begin":569,"end":589},"obj":"diseaseC0004364"}],"relations":[{"id":"0#5#gene5094356#65#diseaseC0033860","pred":"associated_with","subj":"19880293-16#0#5#gene50943","obj":"19880293-16#56#65#diseaseC0033860"},{"id":"6#10#gene3559105#124#diseaseC0004364","pred":"associated_with","subj":"19880293-2#6#10#gene3559","obj":"19880293-2#105#124#diseaseC0004364"},{"id":"6#10#gene3669105#124#diseaseC0004364","pred":"associated_with","subj":"19880293-2#6#10#gene3669","obj":"19880293-2#105#124#diseaseC0004364"},{"id":"70#75#gene50943118#138#diseaseC0004364","pred":"associated_with","subj":"19880293-4#70#75#gene50943","obj":"19880293-4#118#138#diseaseC0004364"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}
tmVarCorpus
{"project":"tmVarCorpus","denotations":[{"id":"T1","span":{"begin":985,"end":1004},"obj":"DNAMutation:c|DEL|-6054|ATT"},{"id":"T2","span":{"begin":1006,"end":1016},"obj":"DNAMutation:c|SUB|A|-3279|C"},{"id":"T3","span":{"begin":1018,"end":1027},"obj":"DNAMutation:c|SUB|A|-924|G"},{"id":"T4","span":{"begin":1029,"end":1042},"obj":"DNAMutation:c|SUB|A|IVS9+459|G"},{"id":"T5","span":{"begin":1959,"end":1977},"obj":"DNAMutation:c|DEL|-6054|ATT"},{"id":"T6","span":{"begin":1986,"end":1994},"obj":"DNAMutation:c|SUB|A|-924|G"}],"text":"Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients.\nBACKGROUND: Psoriasis is a common dermatological disorder, in which autoimmunity plays an important role. CD4(+)CD25(+) regulatory T cells (T-regs) have been suggested to be involved in the pathogenesis of some autoimmune diseases. T-regs express the fork head/winged helix transcription factor, FOXP3, which appears to be of key importance in the development and function of T-regs. Studies have found that single-nucleotide polymorphisms (SNPs) in the FOXP3 gene contribute to susceptibility to some autoimmune disorders. However, information about FOXP3 gene in psoriasis is limited.\nOBJECTIVE: This study evaluated the association between FOXP3 gene SNPs and susceptibility to psoriasis in a Han Chinese population.\nMETHODS: In a hospital-based case-control study, 524 patients with psoriasis and 549 psoriasis-free controls were recruited according to age and gender. We investigated four SNPs in the FOXP3 gene (-6054, deletion/ATT; -3279, A/C; -924, A/G; IVS9+459, A/G) in psoriatic patients, and assessed allele and genotype frequencies in psoriatic patients (237 females, 287 males) and normal controls (272 females, 277 males). The polymorphisms were genotyped using the PCR sequence-specific primer (PCR-SSP) technique and PCR-restriction fragment length polymorphism (RFLP) analysis.\nRESULTS: We found that increased risk of psoriasis was associated with the FOXP3 -3279 AC genotype (adjusted OR, 1.32; 95% CI, 1.01-1.74) and the combined AC+AA genotype (adjusted OR, 1.38; 95% CI, 1.07-1.78), compared with the -3279 CC genotype. We also found that an increased risk of psoriasis was associated with the FOXP3 IVS9+459 GG genotype (adjusted OR, 2.24; 95% CI, 1.41-3.58). However, the combined GA+GG genotype showed no such tendency (adjusted OR=1.28; 95% CI, 1.00-1.64), compared with the IVS9+459 AA genotype. There was no evidence of an increased risk associated with the FOXP3-6054 deletion/ATT or FOXP3-924 A/G genotype. In combined genotype analyses, the FOXP3-3279 AC+AA genotype was more obviously associated in males (adjusted OR=1.60, 95% CI=1.11-2.31) and severe psoriasis patients (PASI score \u003e20; adjusted OR=1.97, 95% CI=1.41-2.75). Meanwhile, the FOXP3 IVS9+459 GA+GG genotype was also associated with severe psoriasis patients (adjusted OR=1.69, 95% CI=1.21-2.36).\nCONCLUSIONS: FOXP3 polymorphisms appear to contribute to the risk of psoriasis in a Han Chinese population. Larger studies are needed to confirm these findings."}